Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to determine whether uFSH is effective and safe in the treatment of male patients with severe oligospermia or azoospermia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Livzon Pharmaceutical Group Inc.

Criteria

Inclusion Criteria:

• Male subjects aged 20~35.

• They accorded with diagnostic criteria of severe oligospermia or azoospermia.

• They had'nt been treated with drug which could improve sperm count and quality one month before observation，otherwise,they should have a elution for 1 month before the study.

Exclusion Criteria:

• Gram-positive bacteria ,Chlamydia trachomatis,Ureaplasmaurealyticum,or mycoplasma hominis were detected in their semen.

• Subjects addicted to drug，tobacco，or alcohol.

• Subjects had heat,chemicals,radioactive material,or toxic contact history within a year.

• Subjects were under treatment of gonadotropin,anabolic steroid,chemotherapeutic drugs,or nonsteroidal anti-inflammatory drugs .

• Subjects combined with cardiovascular, liver, kidney ,or hematopoietic system severe primary disease,or mental disease.

• Subjects were allergic or on uFSH allergy,or under the treatment of other drugs for infertility .

• Subjects did not meet the inclusion criteria, did not according to the prescribed medication, were unable to judge the efficacy ,had incomplete information, or affected the efficacy or safety judgment.

• Subjects were IHH patients